1.Effect of pristimerin on experimental inflammation in mice and rats
Bin HUI ; Yongjie WU ; Hong WANG ; Xuan TIAN
Chinese Pharmacological Bulletin 1986;0(06):-
AIM To study the anti-inflammatory effects and mechanisms of pristimerin. METHODS Several inflammatory models were established, such as ear edema induced by croton oil, hind paw swelling by carrageenan, elevation of capillary permeability by acetic acid in mice and a-cute peritonitis induced by carrageenan in rats. Protein content was measured by Coomassie brilliant blue method, nitric oxide (NO) content by Griess reaction assay, N-acetyl-?-D-glucosamini-dase (NAG) activity by colorimetry, superoxide dismutase (SOD) activity by hydroxylamine method, catalase (CAT) activity by ultraviolet spectro-photometry, and malondialdehyde (MDA) content by fluorescence method in peritoneal exudate in rats. RESULTS Pristimerin ip 0. 156 - 0. 625 mg ? kg-1 or im 1-4 mg - kg-1 inhibited ear edema, hind paw swelling, and elevation of capillary permeability in mice. In the rat peritonitis induced by carrageenan, pristimerin im 1 - 2 mg ?kg-1 reduced neutrophil counts, lessened protein and NO content, inhibited the production of MDA and decreased NAG activity, while augmented the SOD and CAT activity in exudate. CONCLUSION Pristimerin has a significant anti-inflammatory effect which may be related to the inhibition of NO production, scavenging oxygen free radicals, anti-lipoperoxidation and stabilizing lysosome membrane.
2.Interaction of anti-thrombotic and anti-inflammatory activities of commonly used traditional Chinese medicine for promoting blood circulation and removing blood stasis revealed by network pharmacology analysis.
Ming LÜ ; Tai-yi WANG ; Xiao-xuan TIAN ; Xin-hui SHI ; Guan-wei FAN ; Yan ZHANG ; Yan ZHU
Acta Pharmaceutica Sinica 2015;50(9):1135-1141
Chinese traditional patent medicine for promoting blood circulation and removing blood stasis(PBCRBS) originated from traditional Chinese medicine theory and had approved efficacy and safety standards. However, its compatibility regularity and anti-thrombotic mechanism is not clear. To analyze the compatibility regularity and anti-thrombotic mechanism of Chinese traditional patent medicine for PBCRBS, a statistical and bioinformatics analysis was carried out using traditional Chinese medicine inheritance support system (TICMISS, V2.0) and ingenuity pathway analysis (IPA). The compatibility regularity analysis shows that the most commonly used herb combinations are Danshen (Salvia miltiorrhiza Bge.), Chuanxiong (Ligusticum chuanxiong Hort.) and Honghua (Carthamustinctorius L.). The anti-thrombotic mechanism analysis reveals that 25 ingredients have an effect on 29 thrombosis related molecules which 23 molecules are related to inflammation response. Furthermore, there are 5 inflammation molecules (NOS2, PTGS2, IL6, TNF, IL1β) served as major targets. At the same time, Danshen, Chuangxiong and Honghua mainly used as sovereign herb or minister herb in the application of cardiovascular and cerebrovascular diseases. Therefore, Chinese traditional patent medicine for PBCRBS probably has an effect on anti-thrombotic activity through inhibiting the inflammatory response. In summary, the most commonly used herb combinations of Chinese traditional patent medicine for PBCRBS are Danshen, Chuanxiong and Honghua. Inhibiting inflammatory response, especially inflammation related molecules (NOS2, PTGS2, IL6, TNF and IL1β), is probably a new starting point to clarify the anti-thrombotic mechanism of Chinese patent medicine for PBCRBS.
Anti-Inflammatory Agents
;
pharmacology
;
Carthamus tinctorius
;
Computational Biology
;
Drugs, Chinese Herbal
;
pharmacology
;
Fibrinolytic Agents
;
pharmacology
;
Humans
;
Inflammation
;
drug therapy
;
Medicine, Chinese Traditional
3.Response surface methodology applied to the optimization for supercritical CO2 extraction of the lipids from tempeh
ming Zi XIA ; Ying TIAN ; hui Xuan HE ; xing Jun DONG
Journal of International Pharmaceutical Research 2017;44(8):800-806
Objective To optimize the supercritical carbon dioxide(SC-CO2)extraction of lipids from tempeh(TE-C)and further improve the lipid classes ratio. Methods The experimental parameters of SC-CO2 extraction including extraction temperature, pressure,and moisture content of tempeh were optimized using a Box-Behnken design combined with response surface methodology (RSM),according to the weighted extraction ratio of TE-C and lipid classes after the experimental results of single factors. Detailed chemical compositions of TE-C obtained by optimum conditions of SC-CO2 extraction were analyzed by high performance liquid chroma?tography with an evaporative light-scattering detector(HPLC-ELSD)and high performance liquid chromatography-atmospheric pres?sure chemical ionization mass spectrometry(HPLC-APCI-MS). Results TE-C was composed of three lipid classes:fatty acids(Ⅰ), diacylglycerols(Ⅱ)and triacylglycerols(Ⅲ). The optimum SC-CO2 extraction conditions of TE-C were 50℃extraction temperature, 25 MPa pressure,1.99%moisture content of tempeh and 1.5 hour extraction time. Conclusion The optimum value of RSM for SC-CO2 extraction was(5.97±0.15)g/100 g.
4.Chiral separation of fluvastatin enantiomers with in vitro cellular method.
Bo-xuan QU ; Ye TIAN ; Lu-shan YU ; Hui-di JIANG ; Quan ZHOU ; Su ZENG
Journal of Zhejiang University. Medical sciences 2011;40(1):12-16
OBJECTIVETo establish a chiral separation method for determination of fluvastatin enantiomer with in vitro cellular model.
METHODSThe determination was performed on Chiralpak AD column (4.6 mm × 250 mm); and the phase consisted of hexane-isopropanol-trifluoroacetic acid (90:10:0.1) at a flow rate of 0.5 ml/min with UV detection of 239 nm.
RESULTThe standard curve was linear over the concentration range of 20 μmol/L-300 μmol/L (r² = 0.9993, r² = 0.9997). The recovery for this assay was (99.4 ± 0.8)%, precision for inter-assay and intra-assay was <10 %.
CONCLUSIONThe normal-phase HPLC chiral separation method was accurate and suitable for study on the stereoselectivity of fluvastatin with in vitro cellular model.
Cells, Cultured ; Chromatography, High Pressure Liquid ; methods ; Fatty Acids, Monounsaturated ; isolation & purification ; Indoles ; isolation & purification ; Stereoisomerism
5.The changes of some chemical components in banxiaxiexintang decoction of different combinations.
Tian-xuan DUAN ; Chang-hua MA ; Tao CHEN ; Li-hui LUN ; Ryoko OKUMA ; Yuhang LI
China Journal of Chinese Materia Medica 2002;27(5):363-365
OBJECTIVEThe contents of bererine, palmatine and glycyrrhizin acid in Banxiaxiexintang decoction of different combinations were determined by PR-HPLC.
METHODA Shim-pack CLC-ODS column was used with a mobile phase of CH3CN-H2O (31:69; 0.005 moL.L-1 -pentanesulfonic acid sodium salt, H3PO4: pH 3.0) for bererine andpalmatine, which were detected at the wavelength of 275 nm. A YWG-C18 column was used with a mobile phase of CH3OH-H2O-HAc(62:37:1) for glycyrrhizin acid which was detected at the wavelength of 260 nm.
RESULTEach herbs' combination influences the contents of the 3 components.
CONCLUSIONThe experiment is an attempt to study the comical foundation of traditional Chinese prescription.
Berberine ; analysis ; Berberine Alkaloids ; analysis ; Drug Combinations ; Drugs, Chinese Herbal ; analysis ; Glycyrrhizic Acid ; analysis ; Plant Extracts ; chemistry ; Plants, Medicinal ; chemistry
6.Effect of the chelator Zn-DTPA on the excretion of lead in lead intoxication mice detected with ICP-MS.
Chen LI ; Kai-zhi LU ; Qi ZHOU ; Qiong WANG ; Yu-liang ZENG ; Hong-jun YIN ; Xuan-hui HE ; Ying TIAN ; Jun-Xing DONG
Acta Pharmaceutica Sinica 2014;49(11):1588-1592
To study the lead excretion effect of the chelator Zn-DTPA on the lead intoxication mice, inductively coupled plasma mass spectrometry (ICP-MS) was applied to detect the lead content of biological samples. The acute lead intoxication mice model was established by injecting lead acetate intraperitoneally with the dose of 1 mg. Zn-DTPA was administered intraperitoneally to mice once daily for five consecutive days 4 h after intoxication. Control group, model group, combination of Zn-DTPA and Ca-DTPA group were evaluated at the same time. The urine was collected every day. The mice were sacrificed in batches in the 2rd, 4th, 6th day. Biological samples including urine, whole blood, femur and brain were prepared and nitrated. Lead concentration was detected by ICP-MS. The result showed that Zn-DTPA could increase lead content in urine markedly and reduce lead content in blood, femur and brain.
Animals
;
Chelating Agents
;
pharmacology
;
Lead
;
pharmacokinetics
;
urine
;
Lead Poisoning
;
drug therapy
;
Mass Spectrometry
;
Mice
;
Pentetic Acid
;
pharmacology
7.The Specific Application of Case Teaching Method in Medical Ethics:Taking Tumor Patients as Example
Tao TIAN ; Ning LI ; Xuan LIANG ; Zhiping RUAN ; Hui GUO ; Yu YAO
Chinese Medical Ethics 2018;31(3):362-365
The ethical issues involved in the diagnosis and treatment of malignant tumors are increasing. Case teaching method is a teaching mode that has received much attention in recent years. This paper analyzed the com-mon ethical issues faced by clinical oncology at present, including tumor patients' right of informed consent, tumor patients' right of treatment option, and the hospice care for tumor patients and so on, and combined with cases, introduced the application of case teaching method in clinical oncology postgraduate ethics teaching.
8.Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia.
Yu ZHU ; Liang-Qin PAN ; Si-Xuan QIAN ; Ping SONG ; Hui YU ; Su-Jiang ZHANG ; Zheng GE ; Ming HONG ; Tian TIAN ; Jian-Yong LI
Journal of Experimental Hematology 2013;21(3):581-586
This study was aimed to evaluate the efficacy and safety of dasatinib in BCR/ABL positive leukemia patients with primary or secondary resistance to imatinib. 27 patients with primary or secondary imatinib-resistant chronic myelogenous leukemia (CML) or Philadelphia chromosome positive acute lymphocytic leukemia (Ph(+) ALL) received 100 - 140 mg/d dasatinib orally. Their overall survival and tolerance were evaluated. The results showed that the median duration of dasatinib therapy was 8 (1-66) months in the 27 imatinib-resistant BCR/ABL positive leukemia cases, with a median follow-up of 54 (3-75) months. After the dasatinib treatment, 88.8% of all the 27 cases achieved complete hematologic response (CHR), 29.6% of them achieved major cytogenetic response (mCyR), 37% of all achieved complete cytogenetic response (CCyR) and 18.5% cases achieved major molecular response (MMR). Patients who received dasatinib in progress of disease (CML-AP, CML-BC and bone marrow relapse Ph(+) ALL) had a lower CCyR rate than those in stable disease (CML-CP and bone marrow remission Ph(+) ALL) (P = 0.0377), and 3 - 4 grade adverse events occurred more frequently in progress of disease than that in stable disease. Overall survival of the patients who achieved CCyR after dasatinib therapy was statistically longer than those who did not achieve CCyR (63 m vs 9 m, P = 0.0126). The most common grade 3 - 4 adverse events during dasatinib therapy including hematology events such as thrombocytopenia (51.8%), neutropenia (48.1%), anemia (33.3%), and non-hematologic events such as pleural effusion (18.5%), pulmonary infection (18.5%), pericardial effusion (11.1%). The 3-4 grade adverse events occurred within 12 months from dasatinib therapy, and were mainly observed in patients with progress of disease. It is concluded that dasatinib is an effective drug in imatinib-resistant BCR/ABL positive leukemia patients, the better curative effect and better tolerance has been observed in patients who received dasatinib in stable disease.
Adult
;
Aged
;
Benzamides
;
therapeutic use
;
Dasatinib
;
Drug Resistance, Neoplasm
;
Female
;
Fusion Proteins, bcr-abl
;
Humans
;
Imatinib Mesylate
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
blood
;
drug therapy
;
Male
;
Middle Aged
;
Piperazines
;
therapeutic use
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
blood
;
drug therapy
;
Protein Kinase Inhibitors
;
therapeutic use
;
Pyrimidines
;
therapeutic use
;
Thiazoles
;
therapeutic use
;
Treatment Outcome
;
Young Adult
9.Establishment of method collecting peripheral blood hematopoietic stem/progenitor cells from infants.
Shu-Xuan MA ; Xi-Wei XU ; Wen-Qi SONG ; Hui XUE ; Hua SHAO ; Jing-Yun AN ; Jing-Hui TIAN ; Xuan ZHOU ; Mao-Quan QIN ; Jing YE ; Chun-Hua CUI
Journal of Experimental Hematology 2008;16(6):1361-1364
The aim of this study was to explore a safe method collecting peripheral blood stem/progenitor cell (PBSPC) from the infants of body weight less than 20 kg by using the COBE Spectra Blood Cell Separator through Auto-PBSC procedure. After washing tube by normal saline, one unit of irradiated RBC was infused into the apheresis set. When the collection terminated, only the concentrated RBC in the apheresis set was returned to the infant. The peripheral mononuclear cells (PBMNCs) and CD34+ cells were counted, the cell viability was determined. The results showed that 13 PBSPC collections were carried out successfully from 7 infants of body weight<20 kg. The average count of MNCs was 4.44x10(8)/kg [(3.46-6.45)x10(8)/kg], the CD34+ count was 2.20x10(6)/kg [(1.34-3.79)x10(6)/kg] and the cell viability was 98.45% (97%-100%) respectively. The vital signs of all the infants went smoothly during collection of PBSPCs. In conclusion, with the aid of COBE Spectra blood cell separator and other measures, the collection of PBSPCs from infants of body weight<20 kg is safe and effective, the PBMNCs containing enough PBSPC can be harvested for transplantation.
Cell Separation
;
methods
;
Child, Preschool
;
Female
;
Hematopoietic Stem Cell Mobilization
;
methods
;
Hematopoietic Stem Cells
;
Humans
;
Infant
;
Male
10.Study of HLA polymorphism in the 6965 Han bone marrow registry donors.
Guo-guang WU ; Zhi-hui DENG ; Su-qing GAO ; Liang-hong CHENG ; Shi-zheng JIN ; Dan ZHOU ; Zhen LI ; Hong-yan ZOU ; Xuan ZHANG ; Tian-li WEI ; Xi CHENG ; Da-ming WANG
Chinese Journal of Hematology 2004;25(8):473-477
OBJECTIVETo analyze human leukocyte antigen (HLA) polymorphism and search for new alleles in Chinese Han population bone marrow registry donors.
METHODSDNA-based HLA genotyping methods were used including PCR-SSP, BST and molecular cloning.
RESULTSA total of 6965 unrelated donors, 4707 from South China origin and 2258 from north, were typed for HLA-A, B, and DRB1 loci. Seventy-two specificities of HLA alleles were identified. The HLA-A25, A34, A74, B41, B42, B53, B73 and B81 that were rarely reported in previously Chinese population studies were identified in this study. Estimation of gene frequency indicated that the blank gene frequency was less than 0.2% for HLA-A, 0.25% for HLA-B and 0.70% for HLA-DRB1 loci. Three novel alleles were identified and officially assigned by the World Health Organization (WHO) Nomenclature Committee as A*0253N, A*1114 and B*5610.
CONCLUSIONLarge-scale DNA-based HLA genotyping used in bone marrow registry donors is highly accurate and reliable for estimating gene frequency and searching for new alleles. The discrepancy of HLA gene distribution between South and North China Han population showed the necessity of setting the more regions in South and North China to screen the bone marrow registry donors for bone marrow transplant.
Bone Marrow Transplantation ; statistics & numerical data ; China ; ethnology ; Female ; Gene Frequency ; HLA-A Antigens ; genetics ; HLA-B Antigens ; genetics ; HLA-DR Antigens ; genetics ; HLA-DRB1 Chains ; Histocompatibility Antigens Class I ; genetics ; Histocompatibility Antigens Class II ; genetics ; Humans ; Male ; Polymorphism, Genetic ; Registries ; Tissue Donors